+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 40Years - 85Years
All Genders
ID06793371

Randomized, Double-Blind Study to Evaluate Safety and Effects of CK-4021586 in Adults with Symptomatic Heart Failure with Preserved Ejection Fraction

Led by Cytokinetics · Updated on 2026-08-27

60

Participants Needed

26

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase 2 study to find the appropriate dose of CK-4021586 in adults aged 40 to 85 with symptomatic heart failure with preserved ejection fraction HFpEF. The study aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of this drug in people with this condition, which involves heart failure while maintaining a normal ejection fraction. The trial is randomized, double-blind, and placebo-controlled to provide reliable results. Participants may receive different daily doses of CK-4021586 150 mg, 300 mg, 450 mg, or 600 mg for up to 12 weeks, with dosing guided by echocardiography assessments. There are several study groups, including placebo groups, to compare the effects of the drug. The dose levels are organized in cohorts, with participants assigned randomly to receive either the drug or placebo over the 12-week treatment period. During the study, participants will undergo regular evaluations including echocardiography to monitor left ventricular ejection fraction LVEF and blood tests for NT-proBNP levels, a marker of heart failure. The researchers will assess drug safety by tracking adverse events and early discontinuation rates. Blood samples will also be taken to measure drug concentrations and how these relate to changes in heart function. Total participation lasts for 12 weeks, during which participants have scheduled visits for monitoring and assessments.

CONDITIONS

Brief Title

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Research Team

C

Cytokinetics MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here